Autor: |
Justman, Jessica, Skalland, Timothy, Moore, Ayana, Amos, Christopher I., Marzinke, Mark A., Zangeneh, Sahar Z., Kelley, Colleen F., Singer, Rebecca, Mayer, Stockton, Hirsch-Moverman, Yael, Doblecki-Lewis, Susanne, Metzger, David, Barranco, Elizabeth, Ken Ho, Marques, Ernesto T. A., Powers-Fletcher, Margaret, Kissinger, Patricia J., Farley, Jason E., Knowlton, Carrie, Sobieszczyk, Magdalena E. |
Předmět: |
|
Zdroj: |
Emerging Infectious Diseases; Aug2024, Vol. 30 Issue 8, p245-254, 10p |
Abstrakt: |
During January-August 2021, the Community Prevalence of SARS-CoV-2 Study used time/location sampling to recruit a cross-sectional, population-based cohort to estimate SARS-CoV-2 seroprevalence and nasal swab sample PCR positivity across 15 US communities. Survey-weighted estimates of SARS-CoV-2 infection and vaccine willingness among participants at each site were compared within demographic groups by using linear regression models with inverse variance weighting. Among 22,284 persons >2 months of age and older, median prevalence of infection (prior, active, or both) was 12.9% across sites and similar across age groups. Within each site, average prevalence of infection was 3 percentage points higher for Black than White persons and average vaccine willingness was 10 percentage points lower for Black than White persons and 7 percentage points lower for Black persons than for persons in other racial groups. The higher prevalence of SARS-CoV-2 infection among groups with lower vaccine willingness highlights the disparate effect of COVID-19 and its complications. [ABSTRACT FROM AUTHOR] |
Databáze: |
Complementary Index |
Externí odkaz: |
|